MCA
ACHV icon

Magnolia Capital Advisors’s Achieve Life Sciences ACHV Stock Holding History

Magnolia Capital Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.6K Sell
15,100
-9,000
-37% -$42.9K 0.02% 293
2026
Q1 		$70.9K Buy
24,100
+11,250
+88% +$50K 0.01% 278
2025
Q4 		$63.9K Buy
+12,850
New +$56K 0.01% 268

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Magnolia Capital Advisors's ACHV Position: Q2 2026 in Review

Magnolia Capital Advisors reduced its Achieve Life Sciences (ACHV) stake by 37% in Q2 2026, selling an estimated $42.9K and leaving 15,100 shares worth $98.6K. The position accounts for 0.02% of the portfolio, ranked #293.

Magnolia Capital Advisors first reported a position in ACHV in Q4 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Magnolia Capital Advisors held 15,100 shares of Achieve Life Sciences worth $98.6K as of Q2 2026.
  • Magnolia Capital Advisors sold 9,000 Achieve Life Sciences shares in Q2 2026, an estimated $42.9K.
  • Achieve Life Sciences made up 0.02% of Magnolia Capital Advisors's portfolio in Q2 2026, its #293 holding.
  • Magnolia Capital Advisors first reported a position in Achieve Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.